Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 195
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2 Trial in Worldwide (IVA337, Placebo, Empagliflozin)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Diabetes Mellitus, Type 2
  • Homewood, Alabama
  • +40 more
Jan 23, 2023

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +393 more
Jan 17, 2023

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +82 more
Aug 23, 2022

Diabetes, Type 2 Trial in Worldwide (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Canagliflozin 100 mg
  • +2 more
  • Little Rock, Arkansas
  • +121 more
Aug 18, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +105 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Lancaster, California
  • +104 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +107 more
Jul 11, 2022

Diabetes, Type 2 Trial in United States (semaglutide, oral glucose-lowering medications (commercially available))

Recruiting
  • Diabetes Mellitus, Type 2
  • semaglutide
  • oral glucose-lowering medications (commercially available)
  • Alhambra, California
  • +23 more
Jul 8, 2022

Diabetes, Type 2 Trial in Anaheim, Miami, San Antonio (LY3493269, Dulaglutide, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +2 more
Apr 4, 2022

Diabetes, Type 2 Trial in Worldwide (NNC0480-0389, Semaglutide, Placebo (NNC080-0389))

Recruiting
  • Diabetes Mellitus, Type 2
  • Buena Park, California
  • +95 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Saxagliptin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Sacramento, California
  • +122 more
Mar 21, 2022

Diabetes, Type 2 Trial in United States (Gan & Lee Insulin Glargine Injection, Lantus®)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Gan & Lee Insulin Glargine Injection
  • Lantus®
  • Birmingham, Alabama
  • +56 more
Mar 23, 2022

Diabetes, Type 2 Trial in Worldwide (BI 456906, Placebo, Semaglutide)

Completed
  • Diabetes Mellitus, Type 2
  • BI 456906
  • +2 more
  • Huntington Park, California
  • +79 more
Mar 22, 2022

Diabetes, Type 2, Renal Impairment, Healthy Trial in Miami, Orlando, Saint Paul (PF-06882961 20 mg)

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • PF-06882961 20 mg
  • Miami, Florida
  • +2 more
Mar 18, 2022

Diabetes, Type 2 Trial in Worldwide (Alogliptin Benzoate, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Alogliptin Benzoate
  • Placebo
  • Little Rock, Arkansas
  • +54 more
Mar 14, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Anniston, Alabama
  • +228 more
Jan 6, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +3 more
  • Concord, California
  • +166 more
Jan 6, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +184 more
Jul 1, 2021

Diabetes, Type 2 Trial in Worldwide (LY2944876, Exenatide extended-release, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +50 more
May 25, 2021

Diabetes, Type 2 Trial in Miami (JTT-662, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Miami, Florida
    Qps-Mra, Llc
Mar 16, 2021

Diabetes, Type 2 Trial in United States (DA-1241, Placebo, Sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Chula Vista, California
  • +3 more
Feb 9, 2021

NAFLD, Diabetes, Type 2, Hypertriglyceridemia Trial in Canada, United States (Placebo, ISIS 703802 40 mg, ISIS 703802 80 mg)

Completed
Has Results
  • NAFLD
  • +3 more
  • Placebo
  • +3 more
  • Chandler, Arizona
  • +41 more
Jan 28, 2021

Diabetes, Type 2 Trial in United States (LY3437943, Dulaglutide, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +3 more
Jan 18, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +102 more
Jan 14, 2021

Diabetes, Type 2 Trial in United Kingdom, United States (BYM338 10 mg/kg, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • BYM338 10 mg/kg
  • Placebo
  • Anaheim, California
  • +8 more
Dec 9, 2020